Literature DB >> 28009461

Multistaged Nanovaccines Based on Porous Silicon@Acetalated Dextran@Cancer Cell Membrane for Cancer Immunotherapy.

Flavia Fontana1, Mohammad-Ali Shahbazi1, Dongfei Liu1,2, Hongbo Zhang1,2, Ermei Mäkilä3, Jarno Salonen3, Jouni T Hirvonen1, Hélder A Santos1.   

Abstract

Immunoadjuvant porous silicon (PSi)-based nanovaccines are prepared by nanoprecipitation in a glass capillary microfluidics device. Vesicles, derived from cancer cell membranes encapsulating thermally oxidized PSi nanoparticles or PSi-polymer nanosystems binding a model antigen, are biocompatible over a wide range of concentrations, and show immunostimulant properties in human cells, promoting the expression of co-stimulatory signals and the secretion of pro-inflammatory cytokines.
© 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  acetalated dextran; cancer cell membranes; cancer immunotherapy; nanovaccines; porous silicon

Mesh：

Substances：

Year:  2016        PMID： 28009461     DOI： 10.1002/adma.201603239

Source DB:  PubMed          Journal:  Adv Mater        ISSN： 0935-9648            Impact factor:   30.849


  19 in total

Review 1.  Recent advances in porous nanomaterials-based drug delivery systems for cancer immunotherapy.

Authors:  Su-Ran Li; Fang-Yi Huo; Han-Qi Wang; Jing Wang; Chun Xu; Bing Liu; Lin-Lin Bu
Journal:  J Nanobiotechnology       Date:  2022-06-14       Impact factor: 9.429

Review 2.  Cell Membrane Coating Nanotechnology.

Authors:  Ronnie H Fang; Ashley V Kroll; Weiwei Gao; Liangfang Zhang
Journal:  Adv Mater       Date:  2018-03-27       Impact factor: 30.849

Review 3.  Polysaccharide-based nanomedicines for cancer immunotherapy: A review.

Authors:  Yujun Zeng; Yufan Xiang; Ruilong Sheng; Helena Tomás; João Rodrigues; Zhongwei Gu; Hu Zhang; Qiyong Gong; Kui Luo
Journal:  Bioact Mater       Date:  2021-03-18

Review 4.  Hybrid Nanosystems for Biomedical Applications.

Authors:  Joshua Seaberg; Hossein Montazerian; Md Nazir Hossen; Resham Bhattacharya; Ali Khademhosseini; Priyabrata Mukherjee
Journal:  ACS Nano       Date:  2021-01-26       Impact factor: 18.027

5.  Impact of Pore Size and Surface Chemistry of Porous Silicon Particles and Structure of Phospholipids on Their Interactions.

Authors:  Dongfei Liu; Katriina Lipponen; Peng Quan; Xiaocao Wan; Hongbo Zhang; Ermei Mäkilä; Jarno Salonen; Risto Kostiainen; Jouni Hirvonen; Tapio Kotiaho; Hélder A Santos
Journal:  ACS Biomater Sci Eng       Date:  2018-06-14

6.  Biohybrid Vaccines for Improved Treatment of Aggressive Melanoma with Checkpoint Inhibitor.

Authors:  Flavia Fontana; Manlio Fusciello; Christianne Groeneveldt; Cristian Capasso; Jacopo Chiaro; Sara Feola; Zehua Liu; Ermei M Mäkilä; Jarno J Salonen; Jouni T Hirvonen; Vincenzo Cerullo; Hélder A Santos
Journal:  ACS Nano       Date:  2019-05-17       Impact factor: 15.881

Review 7.  Nanoparticle Delivery of Immunostimulatory Agents for Cancer Immunotherapy.

Authors:  Jia Zhuang; Maya Holay; Joon Ho Park; Ronnie H Fang; Jie Zhang; Liangfang Zhang
Journal:  Theranostics       Date:  2019-10-15       Impact factor: 11.556

8.  Artificially cloaked viral nanovaccine for cancer immunotherapy.

Authors:  Manlio Fusciello; Flavia Fontana; Siri Tähtinen; Cristian Capasso; Sara Feola; Beatriz Martins; Jacopo Chiaro; Karita Peltonen; Leena Ylösmäki; Erkko Ylösmäki; Firas Hamdan; Otto K Kari; Joseph Ndika; Harri Alenius; Arto Urtti; Jouni T Hirvonen; Hélder A Santos; Vincenzo Cerullo
Journal:  Nat Commun       Date:  2019-12-17       Impact factor: 14.919

9.  Biomimetic Nanoparticles Camouflaged in Cancer Cell Membranes and Their Applications in Cancer Theranostics.

Authors:  Jiefu Jin; Zaver M Bhujwalla
Journal:  Front Oncol       Date:  2020-01-21       Impact factor: 6.244

10.  Cell-mediated and cell membrane-coated nanoparticles for drug delivery and cancer therapy.

Authors:  Serkan Yaman; Uday Chintapula; Edgar Rodriguez; Harish Ramachandramoorthy; Kytai T Nguyen
Journal:  Cancer Drug Resist       Date:  2020-11-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.